Product Code: ETC8842364 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for granisetron, a medication used to prevent nausea and vomiting caused by chemotherapy and surgery, is expanding in the Philippines due to the rising prevalence of cancer and increased access to oncology treatments. The growing number of cancer treatment centers and improved healthcare coverage have boosted demand for antiemetic drugs like granisetron. Generic drug manufacturers are also playing a significant role in making the medication more affordable. However, competition from alternative antiemetic drugs and pricing pressures may influence market dynamics.
The Philippines granisetron market is being driven by the rising prevalence of cancer and the increasing use of chemotherapy, which necessitates effective antiemetic drugs. Granisetron, widely used to prevent nausea and vomiting in cancer patients undergoing chemotherapy or radiation therapy, has seen growing demand as cancer cases continue to rise. The expansion of healthcare infrastructure, coupled with government initiatives to improve cancer care and access to affordable medicines, is also contributing to market growth. Additionally, pharmaceutical companies are investing in research and development to introduce new and improved formulations of granisetron, further driving the market. The growing medical tourism industry in the Philippines is another factor boosting demand for advanced antiemetic medications.
The granisetron market faces challenges related to the high cost of treatment, which may limit access to the drug for some cancer patients. While granisetron is essential for preventing nausea and vomiting associated with chemotherapy, the overall affordability of cancer treatment remains a challenge in the Philippines. Additionally, the countrys dependence on imported pharmaceuticals increases costs and exposes the market to currency fluctuations. Limited awareness about the drug`s availability in local healthcare facilities may also hinder its widespread use.
The increasing prevalence of cancer and chemotherapy treatments presents investment opportunities in the production, distribution, and innovation of antiemetic drugs like granisetron. Investors can establish local manufacturing facilities for generic and branded versions of granisetron to cater to the growing demand. Partnerships with hospitals, oncology centers, and pharmaceutical retailers can enhance market penetration. R&D in advanced drug delivery systems, such as extended-release formulations, offers further investment potential.
The government ensures access to cancer treatment drugs like granisetron through initiatives under the National Integrated Cancer Control Act. The Philippine Health Insurance Corporation (PhilHealth) provides coverage for chemotherapy-related treatments, including antiemetics like granisetron. The FDA oversees drug pricing and approval to maintain affordability and quality. However, reliance on imports and pricing regulations may affect the availability of granisetron in the local market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Granisetron Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Granisetron Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Granisetron Market - Industry Life Cycle |
3.4 Philippines Granisetron Market - Porter's Five Forces |
3.5 Philippines Granisetron Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Granisetron Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Granisetron Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Granisetron Market Trends |
6 Philippines Granisetron Market, By Types |
6.1 Philippines Granisetron Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Granisetron Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Granisetron Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.1.4 Philippines Granisetron Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.5 Philippines Granisetron Market Revenues & Volume, By Oral, 2021- 2031F |
6.2 Philippines Granisetron Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Granisetron Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Philippines Granisetron Market Revenues & Volume, By Post Operative, 2021- 2031F |
7 Philippines Granisetron Market Import-Export Trade Statistics |
7.1 Philippines Granisetron Market Export to Major Countries |
7.2 Philippines Granisetron Market Imports from Major Countries |
8 Philippines Granisetron Market Key Performance Indicators |
9 Philippines Granisetron Market - Opportunity Assessment |
9.1 Philippines Granisetron Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Granisetron Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Granisetron Market - Competitive Landscape |
10.1 Philippines Granisetron Market Revenue Share, By Companies, 2024 |
10.2 Philippines Granisetron Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |